Religious Liberty Firm to Supreme Court: End this Assault on Little Sisters of the Poor, Religious Organizations
March 10, 2020 09:59 ET
|
First Liberty Institute
WASHINGTON, March 10, 2020 (GLOBE NEWSWIRE) -- First Liberty Institute filed a friend-of-the-court brief in Little Sisters of the Poor v. Pennsylvania urging the Supreme Court of the United States...
Researchers at Queen’s University Belfast have Developed a Vaginal Ring Capable of Providing Sustained Delivery of OB-002 (5P12-RANTES) for HIV Prevention
February 12, 2019 09:00 ET
|
Orion Biotechnology Canada Ltd
OTTAWA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that researchers at the School of Pharmacy, Queen’s University...
Offrez d’abord des contraceptifs intra-utérins, conseillent les pédiatres
May 31, 2018 00:01 ET
|
Société canadienne de pédiatrie
OTTAWA, 31 mai 2018 (GLOBE NEWSWIRE) -- Selon un nouveau document de principes de la Société canadienne de pédiatrie, les contraceptifs intra-utérins devraient être proposés aux adolescentes avant...
Offer youth intrauterine methods of contraception first, paediatricians advise
May 31, 2018 00:01 ET
|
Canadian Paediatric Society
OTTAWA, May 31, 2018 (GLOBE NEWSWIRE) -- Intrauterine methods of contraception should be the first-line birth control option for youth, according to a new position statement from the Canadian...
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
March 14, 2018 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women's healthcare company today announced that an abstract related to the Phase 3 SECURE study for...
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
March 12, 2018 16:15 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three months and year ended...
Agile Therapeutics Reports Third Quarter 2017 Financial Results
November 06, 2017 16:20 ET
|
Agile Therapeutics, Inc.
Cash Expected to Fund Operations into Q2 2018 Prescription Drug User Fee Act (PDUFA) Goal Date for Twirla® is December 26, 2017 PRINCETON, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Agile...
Agile Therapeutics Inc. Hosts First Analyst Day Focused on Previewing its Corporate Vision and Commercial Strategy
October 10, 2017 18:38 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today hosted the Company’s first analyst day in New York City to showcase its...
Agile Therapeutics to Host First Analyst Day on October 10, 2017
October 02, 2017 07:30 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the Company will host its first Analyst Day on Tuesday,...
Agile Therapeutics to Present Additional Phase 3 Data at the North American Forum on Family Planning Annual Meeting
September 28, 2017 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that an abstract based on the Phase 3 SECURE trial of its...